Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Numinus Wellness Inc NUMIF


Primary Symbol: T.NUMI

Healthcare
Numinus Wellness Inc. is a mental health care company. The Company focuses on advancing traditional and behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and... see more

Recent & Breaking News (TSX:NUMI)

Numinus Congratulates MAPS on its Phase 3 Study Results Published in Nature Medicine

PR Newswire September 19, 2023

Numinus Takes Actions to Accelerate its Path to Profitability by Focusing on Positive Cash Flow Generating Operations

PR Newswire September 18, 2023

Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, August 17, 2023

PR Newswire August 9, 2023

Numinus Wellness Inc. Reports Q3 2023 Results

PR Newswire July 17, 2023

Numinus to Present at the Small Cap Growth Virtual Investor Conference on July 13, 2023

PR Newswire July 10, 2023

Numinus to Host Q3 2023 Results Conference Call on July 17, 2023

PR Newswire June 29, 2023

Numinus Announces Agreement with HealingMaps to Drive Strategic Clinic Growth

PR Newswire June 22, 2023

Numinus Announces Partnership with MAPS to Support Therapist Psychedelic Experiential Training

PR Newswire June 15, 2023

Numinus Appoints New Chief Financial Officer

PR Newswire June 14, 2023

Numinus to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on June 20-22, 2023

PR Newswire June 8, 2023

Cedar Clinical Research, by Numinus, the top enrolling clinical research site for MindMed's Phase 2B study evaluating MM-120

PR Newswire June 5, 2023

Numinus to Participate in a Water Tower Research Fireside Chat on Wednesday, June 7, 2023

PR Newswire June 2, 2023

Psychedelics company begins phase 3 psilocybin study for depression

Maor Kagan May 30, 2023

Numinus to research COMP360 psilocybin therapy in treatment-resistant depression as part of large phase 3 study

PR Newswire May 30, 2023

Numinus Aligns Business Initiatives to Prepare for Future Approval of MDMA-Assisted Therapy

PR Newswire May 25, 2023

Numinus Wellness (TSX:NUMI) launches new clinic licensing platform

Trevor Abes  April 18, 2023

Numinus to Participate in a Water Tower Research Fireside Chat on Wednesday, April 19, 2023

PR Newswire April 17, 2023

Numinus Launches New Website to Enhance its Client Experience

PR Newswire April 14, 2023

Numinus Wellness Inc. Reports Q2 2023 Results

PR Newswire April 13, 2023

Numinus Launches new Clinic Licensing Platform, the Numinus Network, to Accelerate Expansion

PR Newswire April 11, 2023